ClinicalTrials.gg
CompletedNCT05465603Updated Jan 5, 2023

Rationale and Analysis of the Use of ETDNO in the Treatment of PIPJ Flexion Contracture:

An interventional study of ETDNO (Elastic Tension digital neoprene orthosis) in Flexion Contracture of Proximal Interphalangeal Joint and Joint Deformities, Acquired, sponsored by Vicenç Punsola Izard. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2023-01-05.

Sponsored by Vicenç Punsola Izard · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Study summary

Introduction: Flexion contracture is one of the most frequent complications in finger trauma. The use of orthoses to obtain the best total end range time (TERT) is the most popular method to treat this pathology . Until now, no orthosis applied for longer than 3 weeks had been able to achieve TERT longer than 12 hours.

Purpose of the study: To assess whether the elastic tension digital neoprene orthosis (ETDNO), using a serial dynamic program, can achieve a better result in ROM and TERT than other orthoses described in the literature.

Methods: analysis of outcomes in a sample of 30 patients with PIP joint flexion contracture treated with the ETDNO and serial dynamic program.

Read the detailed description

In this study the researcher will compare the efect of daily TERT treatment on the proximal interphalangeal joint contracture using an ETDNO. The investigator will treat two different groups one with a dose of from 11 to 13 hours of the ETDNO while the other one is treated with a dose of from 20 to 22 hours of daily TERT with the same device. This treatment will last three weeks and will be evalauted the first day, the he first week and the third week. At the end of the study the researcher will quantify the improvement on both groups to know which dailyTERT dose is the best option.

02

Conditions studied

  • Flexion Contracture of Proximal Interphalangeal Joint
  • Joint Deformities, Acquired
03

In context

Lead sponsor

Vicenç Punsola Izard is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • PIP flexion contracture

Exclusion criteria

Exclusion Criteria:

  • more than 6 month of contracture and more than 45º of flexion contracture
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    20-22 hours of daily TERT intervention

    Patients that have suffered an injury to the finger causing flexion contracture of the Proximal interphalangeal joint will be treated using an elastic tension neoprene orthosis for a period of 3 weeks.

    Device: ETDNO (Elastic Tension digital neoprene orthosis)

  • Active comparator
    11-13 hours daily TERT intervention

    Patients that have suffered an injury to the finger causing flexion contracture of the Proximal interphalangeal joint will be treated using an elastic tension neoprene orthosis for a period of 3 weeks.

    Device: ETDNO (Elastic Tension digital neoprene orthosis)

Interventions

  • DeviceETDNO (Elastic Tension digital neoprene orthosis)

    A bespoke orthosis created from neoprene.

06

What researchers measure

Primary outcomes

  1. Extension improvement

    The degree of extension of the PIP at the end of the treatment compared with the beginning

    Time frame: 3 weeks

07

Study locations

1 site
  • Hand Therapy Barcelona
    Barcelona, Catalonia 08010, Spain
08

References and documents

Individual participant data

Plan to share: No — will be available in the papers published

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05465603
Lead sponsor
Vicenç Punsola Izard
Responsible party
Vicenç Punsola Izard (Physical Therapist, Certified Hand Therapist in Hand Therapy Barcelona, MSc Gimbernat Universiy , Assistant lecturer at Gimbernat University, PhD Candidate at University of Barcelona, Hand Therapy Barcelona) — Sponsor-investigator
First posted
Jul 20, 2022
Start date
Jul 1, 2022
Primary completion
Dec 1, 2022
Completion
Dec 14, 2022
Last update
Jan 5, 2023

Study contacts

Vicenç Punsola-Izard
principal investigator · Hand Therapy Barcelona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion